Adenomyosis (sometimes called “internal endometriosis”) is the presence of endometrial tissue (the lining of the uterus) within the muscle of the uterus; it mainly causes heavy and painful periods, but may also cause no symptoms at all. Long diagnosed only after a hysterectomy, it is now recognised on transvaginal ultrasound and MRI, using standardised ultrasound criteria (MUSA consensus). A meta-analysis of 39 studies published in 2025 links adenomyosis with an increased risk of certain pregnancy complications, such as pre-eclampsia (relative risk 2.24), with a low level of evidence. If you are not planning a pregnancy, the 52 mg levonorgestrel hormonal IUD is often the first treatment offered.
The wall of the uterus has two main layers: the endometrium, the inner lining that renews itself with each cycle, and the myometrium, the thick muscular layer. Between the two lies a transition area called the junctional zone.
In adenomyosis, glands and supporting tissue from the endometrium penetrate into the myometrium. This tissue responds to hormones and causes inflammation and thickening of the surrounding muscle. The uterus may enlarge and become more globular.
A distinction is made between:
Adenomyosis is often associated with endometriosis (lesions located outside the uterus) and with fibroids. They are, however, distinct conditions, with partly different treatments.
Symptoms are varied and not very specific:
Some women have no symptoms at all: adenomyosis is then discovered on an ultrasound performed for another reason. Adenomyosis without symptoms and without plans for pregnancy does not require treatment.
Historically, adenomyosis was described in women over 40 who had had children. Thanks to imaging, we now know that it also affects young women, including those who have never been pregnant.

Gynaecological examination may find an enlarged, globular, sometimes tender uterus. The diagnosis relies on imaging, interpreted together with the symptoms and the examination.
This is the first-line examination. In 2022, a group of European experts revised the MUSA (Morphological Uterus Sonographic Assessment) criteria, which distinguish:
3D ultrasound gives a better view of the junctional zone.
MRI is useful when there is doubt, a large uterus, associated fibroids, or to look for associated endometriosis. It analyses the thickness of the junctional zone: clear thickening points towards adenomyosis. It also better distinguishes an adenomyoma from a fibroid.
| Examination | Advantages | Limitations |
|---|---|---|
| 2D/3D transvaginal ultrasound | Accessible, no radiation, standardised MUSA criteria | Depends on the operator's experience |
| Pelvic MRI | Overall view, measurement of the junctional zone, assessment of associated endometriosis | Less accessible, higher cost |
| Hysteroscopy | Views the inside of the uterus, rules out a polyp or submucosal fibroid | Cannot on its own diagnose adenomyosis |
| Microscopic analysis | Formal confirmation | Only after surgery (most often hysterectomy) |
When periods are heavy, the work-up also looks for other causes: endometrial polyp, fibroid, clotting disorder, hormonal abnormality. A blood test assesses anaemia and iron stores.
Treatment depends on symptoms, age and plans for pregnancy. There is no medicine specific to adenomyosis: the treatments used are similar to those for endometriosis.
The details of these treatments are covered in the article Endometriosis: hormonal treatments and pain relief.
Removal of the uterus is the only definitive treatment for adenomyosis. It is offered when medical treatments have failed or are not tolerated, in a woman who no longer plans a pregnancy. It is most often performed by laparoscopy or vaginally. The ovaries can usually be preserved. Surgical approaches and recovery are detailed in the article Hysterectomy.
For women who wish to keep their uterus, other options exist, though they have been less fully evaluated:
Adenomyosis is found more often in women seeking help for infertility. It may hinder embryo implantation and increase the risk of miscarriage, but studies are heterogeneous. In IVF, hormonal suppression with GnRH agonists before a frozen embryo transfer is sometimes offered; its value is discussed case by case with the medically assisted reproduction centre.
During pregnancy, a meta-analysis of 39 studies published in 2025 in the American Journal of Obstetrics and Gynecology links adenomyosis with an increase in certain risks: pre-eclampsia, preterm birth, low birth weight, haemorrhage after birth, abnormal placental position, miscarriage. The level of evidence is low; the authors recommend tailored antenatal monitoring: tell the team looking after your pregnancy that you have adenomyosis.
See a doctor promptly or call 15 (SAMU) or 112 in France, or your local emergency number, in case of:
The two conditions are closely related and often occur together, but they are distinct: adenomyosis affects the muscle of the uterus, endometriosis is located outside the uterus. An MRI can look for both in the same examination.
Adenomyosis is a benign condition. Abnormal bleeding, particularly after the menopause, must nevertheless always be investigated to rule out another cause.
Symptoms usually decrease markedly after the menopause, when periods stop. This may favour interim medical treatment rather than surgery in a woman close to the menopause.
Yes. Adenomyosis may reduce the chances of pregnancy, but many affected women become pregnant, spontaneously or with medical help. Pregnancy follow-up is adapted to the situation.
No, unless symptoms persist despite treatment and there are no further plans for pregnancy. Many women are relieved by medical treatment, particularly the hormonal IUD.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.